| Name | Ragifilimab |
|---|
| Description | Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research[1]. |
|---|---|
| Related Catalog | |
| Target |
GITR |
| References |
| No Any Chemical & Physical Properties |